인공 자궁 시설 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별 - 예측(2020-2030년)
Artificial Womb Facility Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By End user, By Region and Competition, 2020-2030F
상품코드:1692198
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
인공 자궁 시설 세계 시장은 2024년에는 3억 1,225만 달러로 평가되었고, 2030년까지 연평균 12.27%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
세계 인공자궁 시설 시장은 변화의 기로에 서 있습니다. 의료 기술의 발전과 대체 임신 방법에 대한 관심이 높아지면서 인공자궁은 더 이상 공상과학의 개념이 아닌 현실이 되었습니다. 이 획기적인 혁신은 임신과 출산에 혁명을 일으키고 가족, 의료 서비스 제공업체, 연구자들에게 많은 기회를 제공할 것으로 보입니다. 인공 자궁은 인공 자궁실이라고도 불리며, 자연 자궁의 상태를 재현하여 인체 밖에서 태아의 성장과 발달을 지원하는 장치입니다. 조산아나 위험에 처한 태아가 생존 가능한 단계에 도달할 때까지 계속 발달할 수 있도록 통제된 환경을 제공하는 것을 목적으로 하며, 조산으로 인한 합병증을 줄일 수 있습니다. 이러한 장비는 기존 임신과 관련된 다양한 의학적, 윤리적 문제를 완화하는 데 도움이 될 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
3억 1,225만 달러
시장 규모(2030년)
6억 2,535만 달러
CAGR(2025-2030년)
12.27%
급성장 부문
신생아 의료
최대 시장
북미
시장 성장 촉진요인
모성 사망률 감소가 세계 인공 자궁 시설 시장을 견인합니다.
주요 시장 이슈
윤리적, 도덕적 문제
주요 시장 동향
기술 발전
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 세계의 인공 자궁 시설 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
기술별(바이오리액터, 추출 지원 장비, 기타)
용도별(산전 케어, 신생아 케어)
최종사용자별(전문 병원, 연구센터, 체외수정센터(IVF))
지역별
기업별(2024년)
시장 맵
기술별
용도별
최종사용자별
지역별
제5장 아시아태평양의 인공 자궁 시설 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
기술별
용도별
최종사용자별
국가별
아시아태평양 : 국가별 분석
중국
인도
호주
일본
한국
제6장 유럽의 인공 자궁 시설 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
스페인
이탈리아
영국
제7장 북미의 인공 자궁 시설 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제8장 남미의 인공 자궁 시설 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제9장 중동 및 아프리카의 인공 자궁 시설 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제10장 시장 역학
성장 촉진요인
과제
제11장 시장 동향과 발전
최근 동향
제품 출시
인수합병(M&A)
제12장 세계의 인공 자궁 시설 시장 : SWOT 분석
제13장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
American University of Beirut(AUB)
Biotex Inc.
California Preterm Birth Initiative
Emmaus Life Sciences, Inc.
Hebrew University
Institute of Life Sciences
Juno Perinatal Healthcare
Sera Prognostics, Inc.
Shanghai First Maternity and Infant Hospital
SomaGenics Inc.
제15장 전략적 제안
제16장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
Global Artificial Womb Facility Market was valued at USD 312.25 Million in 2024 and is expected to reach USD 625.35 Million in the forecast period with a CAGR of 12.27% through 2030. The Global Artificial Womb Facility Market is on the brink of transformation. With advancements in medical technology and a growing interest in alternative methods of gestation, the artificial womb is no longer just a concept from science fiction but a reality. This groundbreaking innovation promises to revolutionize pregnancy and childbirth, offering a multitude of opportunities for families, healthcare providers, and researchers. An artificial womb, also known as an ectogenesis chamber, is a device that replicates the conditions of a natural womb to support the growth and development of a fetus outside of a human body. It aims to provide a controlled environment where a preterm or at-risk fetus can continue to develop until it reaches a viable stage, potentially reducing the complications associated with premature births. These devices can be instrumental in alleviating various medical and ethical challenges associated with traditional pregnancies.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 312.25 Million
Market Size 2030
USD 625.35 Million
CAGR 2025-2030
12.27%
Fastest Growing Segment
Neonatal Care
Largest Market
North America
Key Market Drivers
Reduction in Maternal Mortality is Driving the Global Artificial Womb Facility Market
Maternal mortality, a tragic and largely preventable occurrence, has long been a global concern. The World Health Organization (WHO) defines maternal mortality as the death of a woman during pregnancy, childbirth, or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy. While significant progress has been made in reducing maternal mortality rates worldwide, it continues to be a critical issue, particularly in developing countries. As we strive for better healthcare outcomes, one innovative solution is emerging as a potential game-changer: the artificial womb facility. This technology has the potential to significantly reduce maternal mortality and drive the global artificial womb facility market. Maternal mortality is a multifaceted problem that reflects not only the health of women but also the accessibility and quality of healthcare services. The root causes of maternal mortality are varied and complex, including inadequate prenatal care, limited access to healthcare facilities, cultural and social factors, and medical complications during pregnancy and childbirth. According to the WHO, approximately 810 women die every day from preventable causes related to pregnancy and childbirth. This equates to over 295,000 maternal deaths annually. Artificial wombs, often referred to as "ectogenesis," are a groundbreaking technological development in the field of reproductive medicine. These devices aim to provide an environment outside the human body where a developing fetus can thrive. While still in the experimental stage, artificial wombs hold the promise of transforming reproductive healthcare by reducing the risks associated with pregnancy and childbirth. One of the most significant advantages of artificial wombs is the potential to eliminate many of the risks that pregnant women face during the gestational period. Maternal mortality often results from complications related to pregnancy, including preeclampsia, hemorrhage, infections, and obstructed labor. With artificial wombs, the fetus can be safely nurtured outside the mother's body, reducing the risk of these life-threatening complications.
Key Market Challenges
Ethical and Moral Concerns
The ethical and moral concerns surrounding artificial wombs are significant and complex. Questions about when life begins, the potential for misuse, and the creation of a dystopian society where human reproduction is entirely divorced from natural processes have raised red flags among many stakeholders. Striking a balance between technological progress and ethical considerations is a daunting task that the market must confront.
Key Market Trends
Technological Advancements
Technological advancements have played a pivotal role in transforming various aspects of our lives. In recent years, these advancements have extended their reach into the field of healthcare and, specifically, artificial womb technology. The development and adoption of artificial womb facilities are on the rise, driven by increasing technological innovations, which have the potential to revolutionize the way we care for premature babies and address various reproductive health challenges. The progress in biotechnology has led to significant breakthroughs in artificial womb technology. Biocompatible materials, improved incubation systems, and better understanding of fetal development have made it possible to create an environment that closely mimics the mother's womb. Artificial placenta systems have been developed to provide the necessary oxygen and nutrients to the developing fetus, effectively bypassing the need for a natural placenta. This breakthrough technology is a game-changer for the care of premature infants. Technological advancements have allowed for the miniaturization of components, making artificial womb facilities more compact and efficient. This portability can potentially enable care for premature infants in various healthcare settings.
Key Market Players
American University of Beirut (AUB)
Biotex Inc.
California Preterm Birth Initiative
Emmaus Life Sciences, Inc.
Hebrew University
Institute of Life Sciences
Juno Perinatal Healthcare
Sera Prognostics, Inc.
Shanghai First Maternity and Infant Hospital
SomaGenics Inc.
Report Scope:
In this report, the Global Artificial Womb Facility Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Artificial Womb Facility Market, By Technology:
Bioreactors
Extrauter in Support Devices
Others
Artificial Womb Facility Market, By Application:
Prenatal Care
Neonatal Care
Artificial Womb Facility Market, By End user:
Super Specialty Hospitals
Research Centers
In-Vitro Fertilization Centers (IVF)
Artificial Womb Facility Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Artificial Womb Facility Market.
Available Customizations:
Global Artificial Womb Facility market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Artificial Womb Facility Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (Bioreactors, Extrauter in Support Devices, Others)
4.2.2. By Application (Prenatal Care, Neonatal Care)
4.2.3. By End user (Super Specialty Hospitals, Research Centers, In-Vitro Fertilization Centers (IVF))
4.2.4. By Region
4.2.5. By Company (2024)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Application
4.3.3. By End user
4.3.4. By Region
5. Asia Pacific Artificial Womb Facility Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Application
5.2.3. By End user
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Artificial Womb Facility Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Application
5.3.1.2.3. By End user
5.3.2. India Artificial Womb Facility Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Application
5.3.2.2.3. By End user
5.3.3. Australia Artificial Womb Facility Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Application
5.3.3.2.3. By End user
5.3.4. Japan Artificial Womb Facility Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Application
5.3.4.2.3. By End user
5.3.5. South Korea Artificial Womb Facility Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Application
5.3.5.2.3. By End user
6. Europe Artificial Womb Facility Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Application
6.2.3. By End user
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Artificial Womb Facility Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Application
6.3.1.2.3. By End user
6.3.2. Germany Artificial Womb Facility Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Application
6.3.2.2.3. By End user
6.3.3. Spain Artificial Womb Facility Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Application
6.3.3.2.3. By End user
6.3.4. Italy Artificial Womb Facility Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Application
6.3.4.2.3. By End user
6.3.5. United Kingdom Artificial Womb Facility Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Application
6.3.5.2.3. By End user
7. North America Artificial Womb Facility Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End user
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Artificial Womb Facility Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Application
7.3.1.2.3. By End user
7.3.2. Mexico Artificial Womb Facility Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Application
7.3.2.2.3. By End user
7.3.3. Canada Artificial Womb Facility Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Application
7.3.3.2.3. By End user
8. South America Artificial Womb Facility Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End user
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Artificial Womb Facility Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Application
8.3.1.2.3. By End user
8.3.2. Argentina Artificial Womb Facility Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Application
8.3.2.2.3. By End user
8.3.3. Colombia Artificial Womb Facility Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Application
8.3.3.2.3. By End user
9. Middle East and Africa Artificial Womb Facility Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Application
9.2.3. By End user
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Artificial Womb Facility Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Application
9.3.1.2.3. By End user
9.3.2. Saudi Arabia Artificial Womb Facility Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Application
9.3.2.2.3. By End user
9.3.3. UAE Artificial Womb Facility Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Application
9.3.3.2.3. By End user
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Artificial Womb Facility Market: SWOT Analysis
13. Porter's Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. American University of Beirut (AUB)
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Biotex Inc.
14.3. California Preterm Birth Initiative
14.4. Emmaus Life Sciences, Inc.
14.5. Hebrew University
14.6. Institute of Life Sciences
14.7. Juno Perinatal Healthcare
14.8. Sera Prognostics, Inc.
14.9. Shanghai First Maternity and Infant Hospital
